These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
86 related items for PubMed ID: 9351124
1. Therapeutic potential of S-nitrosothiols as nitric oxide donor drugs. Megson IL, Greig IR, Butler AR, Gray GA, Webb DJ. Scott Med J; 1997 Jun; 42(3):88-9. PubMed ID: 9351124 [No Abstract] [Full Text] [Related]
2. S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery. Sogo N, Campanella C, Webb DJ, Megson IL. Br J Pharmacol; 2000 Nov; 131(6):1236-44. PubMed ID: 11082133 [Abstract] [Full Text] [Related]
4. Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryl trinitrate-tolerant rat femoral arteries. Miller MR, Megson IL, Roseberry MJ, Mazzei FA, Butler AR, Webb DJ. Eur J Pharmacol; 2000 Sep 01; 403(1-2):111-9. PubMed ID: 10969151 [Abstract] [Full Text] [Related]
5. Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryltrinitrate-tolerant rat femoral arteries. Miller MR, Roseberry MJ, Mazzei FA, Butler AR, Webb DJ, Megson IL. Eur J Pharmacol; 2000 Nov 24; 408(3):335-43. PubMed ID: 11090652 [Abstract] [Full Text] [Related]
6. Vasodilator action of the S-nitrosothiol, SNAP, in rat isolated perfused lung. Emery CJ. Physiol Res; 1995 Nov 24; 44(1):19-24. PubMed ID: 8789295 [Abstract] [Full Text] [Related]
7. Iron-sulphur cluster nitrosyls, a novel class of nitric oxide generator: mechanism of vasodilator action on rat isolated tail artery. Flitney FW, Megson IL, Flitney DE, Butler AR. Br J Pharmacol; 1992 Nov 24; 107(3):842-8. PubMed ID: 1472976 [Abstract] [Full Text] [Related]
9. Role of nitric oxide and prostaglandins in mechanically induced bone formation. Chow JW, Fox SW, Lean JM, Chambers TJ. J Bone Miner Res; 1998 Jun 01; 13(6):1039-44. PubMed ID: 9626636 [Abstract] [Full Text] [Related]
10. Inhibition of human platelet aggregation by a novel S-nitrosothiol is abolished by haemoglobin and red blood cells in vitro: implications for anti-thrombotic therapy. Megson IL, Sogo N, Mazzei FA, Butler AR, Walton JC, Webb DJ. Br J Pharmacol; 2000 Dec 01; 131(7):1391-8. PubMed ID: 11090112 [Abstract] [Full Text] [Related]
11. Neocuproine, a selective Cu(I) chelator, and the relaxation of rat vascular smooth muscle by S-nitrosothiols. Al-Sa'doni HH, Megson IL, Bisland S, Butler AR, Flitney FW. Br J Pharmacol; 1997 Jul 01; 121(6):1047-50. PubMed ID: 9249237 [Abstract] [Full Text] [Related]
12. Ruthenium complexes as nitric oxide scavengers: a potential therapeutic approach to nitric oxide-mediated diseases. Fricker SP, Slade E, Powell NA, Vaughan OJ, Henderson GR, Murrer BA, Megson IL, Bisland SK, Flitney FW. Br J Pharmacol; 1997 Dec 01; 122(7):1441-9. PubMed ID: 9421293 [Abstract] [Full Text] [Related]
13. Control of NO concentration in solutions of nitrosothiol compounds by light. Zhelyaskov VR, Gee KR, Godwin DW. Photochem Photobiol; 1998 Mar 01; 67(3):282-8. PubMed ID: 9523529 [Abstract] [Full Text] [Related]
14. Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate. Marks GS, McLaughlin BE, Jimmo SL, Poklewska-Koziell M, Brien JF, Nakatsu K. Drug Metab Dispos; 1995 Nov 01; 23(11):1248-52. PubMed ID: 8591726 [Abstract] [Full Text] [Related]
15. A novel family of S-nitrosothiols: chemical synthesis and biological actions. Al-Sa'doni HH, Khan IY, Poston L, Fisher I, Ferro A. Nitric Oxide; 2000 Dec 01; 4(6):550-60. PubMed ID: 11139363 [Abstract] [Full Text] [Related]
16. Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level. Andrew PJ, Harant H, Lindley IJ. Biochem Biophys Res Commun; 1995 Sep 25; 214(3):949-56. PubMed ID: 7575568 [Abstract] [Full Text] [Related]
17. Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP. Edwards JC, Ignarro LJ, Hyman AL, Kadowitz PJ. J Pharmacol Exp Ther; 1984 Jan 25; 228(1):33-42. PubMed ID: 6319670 [Abstract] [Full Text] [Related]
18. New chemical and biological aspects of S-nitrosothiols. Wang K, Zhang W, Xian M, Hou YC, Chen XC, Cheng JP, Wang PG. Curr Med Chem; 2000 Aug 25; 7(8):821-34. PubMed ID: 10828289 [Abstract] [Full Text] [Related]
19. Promotion of proliferation of murine BALB/C3T3 fibroblasts mediated by nitric oxide at lower concentrations. Du M, Islam MM, Lin L, Ohmura Y, Moriyama Y, Fujimura S. Biochem Mol Biol Int; 1997 Mar 25; 41(3):625-31. PubMed ID: 9090471 [Abstract] [Full Text] [Related]
20. Prolonged effect of a novel S-nitrosated glyco-amino acid in endothelium-denuded rat femoral arteries: potential as a slow release nitric oxide donor drug. Megson IL, Greig IR, Gray GA, Webb DJ, Butler AR. Br J Pharmacol; 1997 Dec 25; 122(8):1617-24. PubMed ID: 9422806 [Abstract] [Full Text] [Related] Page: [Next] [New Search]